Xylazine-induced diuresis in rats is attenuated by κ-opioid receptor and α2-adrenoceptor antagonists
Saadet Inan, Scott M Rawls · 2026
Read Xylazine-induced diuresis in rats is attenuated by κ-opioid receptor and α2-adrenoceptor antagonists by Saadet Inan, Scott M Rawls (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13593717.txt.
Description
Saadet Inan and Scott M Rawls asked which receptors make rats pass more urine after a dose of xylazine, a veterinary sedative now turning up as an adulterant in illicit opioids. Xylazine was recently found to act strongly at kappa-opioid receptors, a class known to raise urine output, so their 2026 rat experiments tested two blocking drugs against it.
Xylazine raised urine output in a dose-dependent way over two hours in metabolic cages. Pretreatment with a kappa-opioid blocker cut that increase, and so did pretreatment with yohimbine, which blocks the alpha-2 receptors xylazine was long known for. Neither system alone explains the effect. The authors say anyone interpreting xylazine's actions in the body, especially as its role in overdose cases grows, needs to reckon with both receptor systems at once.
Catalog record
| CREATOR | Saadet Inan, Scott M Rawls |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17177 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |